Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Chinese Medicine
  4. Vol 4, Issue 4, 2022

Research Progress of Traditional Chinese Medicine in the Treatment of Diabetes Complicated with Osteoporosis

Download as PDF

DOI: 10.23977/medcm.2022.040402 | Downloads: 10 | Views: 539

Author(s)

Yao Yao 1, Defen Wang 2, Fang Xiang 1, Ying Luo 1

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Xi'an Hospital of Traditional Chinese Medicine, Xi'an, Shaanxi, 710021, China

Corresponding Author

Defen Wang

ABSTRACT

Diabetes mellitus combined with osteoporosis (OP) is characterized by hyperglycemia and decreased bone density. The slight decrease of bone density causes systemic progressive bone pain, and the severe one causes brittle fracture of hip and lumbar spine. With the acceleration of aging process, the incidence rate also increases year by year, which increases the medical burden of the society. In recent years, the understanding of TCM and TCM treatment of this disease are more and more abundant, and the clinical effect is remarkable. This article reviews the research progress of TCM treatment of diabetes with osteoporosis in order to better guide the clinical practice.

KEYWORDS

Diabetes with Osteoporosis, Traditional Chinese Medicine, Research Progress, Overview

CITE THIS PAPER

Yao Yao, Defen Wang, Fang Xiang, Ying Luo, Research Progress of Traditional Chinese Medicine in the Treatment of Diabetes Complicated with Osteoporosis. MEDS Chinese Medicine (2022) Vol. 4: 8-14. DOI: http://dx.doi.org/10.23977/medcm.2022.040402.

REFERENCES

[1] Liang, Yanhong. Effect of liraglutide plus alfacalcidol on BALP, OPG, apelin-13 levels in diabetic patients with osteoporosis [J]. Jilin Medical Science, 2022, 43 (07): 1891-1893.
[2] Ying Dawen, Liu Fang. Development of a correlation between diabetes and osteoporosis [J]. Practical preventive medicine, 2015, 22 (10): 1275-1278.
[3] Xu Wenxia, Shu Yiqiong. Therapeutic advances in Chinese medicine for diabetic osteoporosis [J]. Journal of clinical Chinese medicine, 2018, 30 (12): 2322-2324. 
[4] Shi Fanfan, Zhao Jirong, Ma Tong, et al. The mechanism of TCM treatment of diabetes osteoporosis based on "Spleen Kidney Theory" [J]. Shaanxi traditional Chinese medicine, 2022,43 (05): 604-607.
[5] Jin Yixi, Feng Xingzhong. Discussion on the pathogenesis and treatment of osteoporosis in elderly patients with diabetes [J].  Guide to traditional Chinese medicine, 2015,21 (16): 96-99.  
[6] Chu Shufang, Zhao hengxia, Liu Deliang, et al. TCM prevention and treatment of type 2 diabetes complicated with osteoporosis [J] World traditional Chinese medicine, 2018,13 (7): 1804-1808.
[7] Liu juntong, Yang Yufeng, Cao Bin, et al. Research on theoretical framework of TCM etiology and pathogenesis of diabetes osteoporosis [J]. Journal of Liaoning University of traditional Chinese medicine, 2019, 21 (06): 110-113.
[8] Chen Guoxun, Wang Mingchao, Xu Changpeng, et al. Research progress of traditional Chinese medicine in treating type 2 diabetes with osteoporosis [J]. Hebei Traditional Chinese medicine, 2017,39 (6): 941-944.
[9] Wang Sihai, Fang Zhaohui, Zhao Jindong. Fang Zhaohui's experience in treating type 2 diabetes with osteoporosis [J]. Chinese Journal of clinical health care. 2020, 05: 679-682.
[10] Liu Ju, Mei qunchao, Zhang Linying, et al. Effect of Bushen Huoxue Recipe on bone metabolic markers and bone mineral density in elderly patients with type 2 diabetes complicated with osteoporosis [J]. Journal of traditional Chinese medicine, 2018,33 (07): 1226-1229.
[11] Yi-chang Jiang et al. UPLC-MS metabolomics method provides valuable insights into the effect and underlying mechanisms of Rhizoma Drynariae protecting osteoporosis [J]. Journal of Chromatography B, 2020, 1152.
[12] Lin Haixiong, Wang Xiaotong, Wang Ligang et al. Drynariae RhizomaIdentified the Synergistic Mechanism of for Treating Fracture Based on Network Pharmacology. [J]. Evid Based Complement Alternat Med, 2019, 2019: 7342635.
[13] Zhao Dun, Fang bin, Yi Chunzhi, et al. Effects of total flavonoids of Drynaria on bone tissue remodeling, bone morphogenetic protein 2, vascular endothelial growth factor and CD31 [J]. China tissue engineering research, 2022,26 (29): 4638-4642.
[14] Hu Yimei, Mu Panyun, Ma Xu et al. Rhizoma drynariae total flavonoids combined with calcium carbonate ameliorates bone loss in experimentally induced Osteoporosis in rats via the regulation of Wnt3a/β-catenin pathway. [J]. J Orthop Surg Res, 2021, 16: 702.
[15] Wu Keliang, Han Linjing, Zhao Ying et al. Deciphering the molecular mechanism underlying the effects of epimedium on osteoporosis through system bioinformatic approach. [J]. Medicine (Baltimore), 2022, 101: e29844.
[16] Liu Yaoyao, Liu Xiangning, Tian Yinping, et al. Research progress of pharmacological mechanism of Icariin on skeletal system [J]. New Chinese medicine and clinical pharmacology, 2020,31 (12): 1516-1520.
[17] Wang Xiaofei, Li Jingjing. Effect of total flavonoids of Epimedium on the expression of notch and Smads pathway proteins in aged osteoporosis rats [J]. Chinese Journal of orthopedics and traumatology, 2019,27 (02): 1-5.
[18] Huang Di, Zi Hui. Research progress of epimedium and its active ingredients in the prevention and treatment of osteoporosis [J]. Journal of practical Chinese medicine, 2022,36 (06): 54-57.
[19] Wei QiuShi, He MinCong, Chen MeiHui et al. Icariin stimulates osteogenic differentiation of rat bone marrow stromal stem cells by increasing TAZ expression. [J]. Biomed Pharmacother, 2017, 91: 581-589.
[20] Liu Haiyan. Clinical observation on the treatment of osteoporosis with Epimedium [J]. Inner Mongolia traditional Chinese medicine, 2019,38 (01): 16-17.
[21] Tu Yan, Xiong Lina, Liu Xiangjie, et al. Observation on the clinical effect of Epimedium combined with danxiankanggu capsule in treating senile osteoporosis [J]. Anhui medicine, 2018,22 (09): 1814-1817.
[22] Liu Bo, Zhang Rui, Xu Peng, et al. Effect of Epimedium on osteoporosis in ovariectomized rats [J]. Chinese Journal of experimental formulary, 2013, 19 (07): 178-181.
[23] Yang Kuo, Gao Rong, Shen Baode, et al. Research Progress on pharmacological effects and mechanism of liver and kidney injury of isopsoralen [J]. evaluation and analysis of drug use in Chinese hospitals, 2021, 21 (11): 1399-1403+1408.
[24] Liu Rui, Yang Xiaojie, Li Xin, et al. Study on the effect of isopsoralen on bone metabolism in ovariectomized rats [J]. Chinese Journal of osteoporosis, 2017,23 (06): 807-811.
[25] Shang Yanchun, Zhang Haiying, Chai Weiwei. Discussion on the effect of isopsoralen on improving bone metabolism in osteoporosis rats [J]. Chinese Journal of osteoporosis, 2021,27 (02): 220-224.
[26] Chai Lijuan, Zhou Kun, Wang Shaoxia et al. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro. [J]. Cell Physiol Biochem, 2018, 48: 2123-2133.
[27] Wang Jian, Zhang Chi. Based on Wnt/ β- Study on the effect of psoralen on osteoporosis rats through the catenin pathway [J / OL]. World traditional Chinese medicine: 1-6 [2022-08-09].
[28] Kong Lingbo, Ma Rui, Yang Xiaobin et al. Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines. [J]. Int Immunopharmacol, 2017, 51: 31-39.
[29] Wei Ruoyu, Zhang Zengjian. Clinical observation of Qishu Tanggu Decoction in treating postmenopausal women with diabetes and osteoporosis [J]. New world of diabetes, 2020, 23 (07): 63-65.
[30] Zhang Zhenhua, Rong Fang, Li Fang, et al. Study on the application of Bushen Jianpi Huoxue Decoction in diabetes patients with osteoporosis [J]. Electronic Journal of modern medicine and health research, 2022,6 (03): 90-93.
[31] Zhang Yongqing, Liu Mingming, Li Haisheng et al. Traditional Chinese medicine Bushen-Jianpi-Huoxue decoction prevents diabetic osteoporosis in rats via Wnt and nuclear factor-kappa B signaling pathways. [J]. Int J Rheum Dis, 2017, 20: 941-948.
[32] Lou Yan, Yu Xu, Sun Xinyi, et al. Experimental study on the intervention of Qikui Granule on type 2 diabetes rats with osteoporosis [J]. Western traditional Chinese medicine, 2022, 35 (06): 25-28.
[33] Lu Zhaoqi, Huang Minling, Lin Haixiong et al. Network pharmacology and molecular docking approach to elucidate the mechanisms of Liuwei Dihuang pill in diabetic osteoporosis. [J]. J Orthop Surg Res, 2022, 17: 314.
[34] Li Huilin, Chu Shufang, Zhao Hengxia et al. Effect of Zishen Jiangtang Pill, a Chinese Herbal Product, on Rats with Diabetic Osteoporosis. [J]. Evid Based Complement Alternat Med, 2018, 2018: 7201914.
[35] Lian Lirong, Chu Shufang, Liang Jiachang, et al. Exploration on the mechanism of Zishen Jiangtang pill in treating osteoporosis in diabetes [J]. Chinese Journal of osteoporosis, 2022, 28 (04): 551-557.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 4346
Visits: 173326

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.